Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Long-term Control Medications
  • 1.3.3 Quick-relief Medications (Rescue Medications)
  • 1.3.4 Medications for Allergy-induced Asthma
• 1.4 Market Segment by Application
  • 1.4.1 Global Anti-Asthmatic Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacy
  • 1.4.3 Retail Pharmacy
  • 1.4.4 Online Pharmacy
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Asthmatic Drugs Market Size
  • 2.1.1 Global Anti-Asthmatic Drugs Revenue 2014-2025
  • 2.1.2 Global Anti-Asthmatic Drugs Sales 2014-2025
• 2.2 Anti-Asthmatic Drugs Growth Rate by Regions
  • 2.2.1 Global Anti-Asthmatic Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Anti-Asthmatic Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Anti-Asthmatic Drugs Sales by Manufacturers
  • 3.1.1 Anti-Asthmatic Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Anti-Asthmatic Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Anti-Asthmatic Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anti-Asthmatic Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Anti-Asthmatic Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Anti-Asthmatic Drugs Price by Manufacturers
• 3.4 Key Manufacturers Anti-Asthmatic Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Anti-Asthmatic Drugs Market
• 3.6 Key Manufacturers Anti-Asthmatic Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Long-term Control Medications Sales and Revenue (2014-2019)
  • 4.1.2 Quick-relief Medications (Rescue Medications) Sales and Revenue (2014-2019)
  • 4.1.3 Medications for Allergy-induced Asthma Sales and Revenue (2014-2019)
• 4.2 Global Anti-Asthmatic Drugs Sales Market Share by Type
• 4.3 Global Anti-Asthmatic Drugs Revenue Market Share by Type
• 4.4 Anti-Asthmatic Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Anti-Asthmatic Drugs Sales by Application

6 United States

• 6.1 United States Anti-Asthmatic Drugs Breakdown Data by Company
• 6.2 United States Anti-Asthmatic Drugs Breakdown Data by Type
• 6.3 United States Anti-Asthmatic Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Anti-Asthmatic Drugs Breakdown Data by Company
• 7.2 European Union Anti-Asthmatic Drugs Breakdown Data by Type
• 7.3 European Union Anti-Asthmatic Drugs Breakdown Data by Application

8 China

• 8.1 China Anti-Asthmatic Drugs Breakdown Data by Company
• 8.2 China Anti-Asthmatic Drugs Breakdown Data by Type
• 8.3 China Anti-Asthmatic Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Anti-Asthmatic Drugs Breakdown Data by Company
• 9.2 Rest of World Anti-Asthmatic Drugs Breakdown Data by Type
• 9.3 Rest of World Anti-Asthmatic Drugs Breakdown Data by Application
• 9.4 Rest of World Anti-Asthmatic Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Anti-Asthmatic Drugs Sales by Countries
  • 9.4.2 Rest of World Anti-Asthmatic Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Abdi Ibrahim
  • 10.1.1 Abdi Ibrahim Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.1.4 Anti-Asthmatic Drugs Product Introduction
  • 10.1.5 Abdi Ibrahim Recent Development
• 10.2 Ception Therapeutics
  • 10.2.1 Ception Therapeutics Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.2.4 Anti-Asthmatic Drugs Product Introduction
  • 10.2.5 Ception Therapeutics Recent Development
• 10.3 Elan
  • 10.3.1 Elan Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.3.4 Anti-Asthmatic Drugs Product Introduction
  • 10.3.5 Elan Recent Development
• 10.4 Innoviva
  • 10.4.1 Innoviva Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.4.4 Anti-Asthmatic Drugs Product Introduction
  • 10.4.5 Innoviva Recent Development
• 10.5 Novartis
  • 10.5.1 Novartis Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.5.4 Anti-Asthmatic Drugs Product Introduction
  • 10.5.5 Novartis Recent Development
• 10.6 Sanofi
  • 10.6.1 Sanofi Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.6.4 Anti-Asthmatic Drugs Product Introduction
  • 10.6.5 Sanofi Recent Development
• 10.7 Mitsubishi Tanabe Pharma
  • 10.7.1 Mitsubishi Tanabe Pharma Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.7.4 Anti-Asthmatic Drugs Product Introduction
  • 10.7.5 Mitsubishi Tanabe Pharma Recent Development
• 10.8 Menarini
  • 10.8.1 Menarini Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.8.4 Anti-Asthmatic Drugs Product Introduction
  • 10.8.5 Menarini Recent Development
• 10.9 Dong-A Socio Holdings
  • 10.9.1 Dong-A Socio Holdings Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.9.4 Anti-Asthmatic Drugs Product Introduction
  • 10.9.5 Dong-A Socio Holdings Recent Development
• 10.10 Lonza
  • 10.10.1 Lonza Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Anti-Asthmatic Drugs
  • 10.10.4 Anti-Asthmatic Drugs Product Introduction
  • 10.10.5 Lonza Recent Development
• 10.11 Sosei
• 10.12 Regeneron Pharmaceuticals
• 10.13 Theravance Biopharma
• 10.14 Lonza

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Anti-Asthmatic Drugs Sales Channels
  • 11.2.2 Anti-Asthmatic Drugs Distributors
• 11.3 Anti-Asthmatic Drugs Customers

12 Market Forecast

• 12.1 Global Anti-Asthmatic Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Anti-Asthmatic Drugs Sales Forecast by Type
• 12.3 Global Anti-Asthmatic Drugs Sales Forecast by Application
• 12.4 Anti-Asthmatic Drugs Forecast by Regions
  • 12.4.1 Global Anti-Asthmatic Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Anti-Asthmatic Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Anti-Asthmatic Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Asthmatic Drugs.

This report studies the global market size of Anti-Asthmatic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Asthmatic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abdi Ibrahim
Ception Therapeutics
Elan
Innoviva
Novartis
Sanofi
Mitsubishi Tanabe Pharma
Menarini
Dong-A Socio Holdings
Lonza
Sosei
Regeneron Pharmaceuticals
Theravance Biopharma
Lonza

Market Segment by Product Type
Long-term Control Medications
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma

Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-Asthmatic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Asthmatic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-Asthmatic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025